くすりのしおり

Internal
Revised: 5/2016

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
LANSOPRAZOLE OD TABLETS 15mg "TOWA" [for gastrointestinal disease]
 Active ingredient:
Lansoprazole
 Dosage form:
white to yellowish white tablet with red-orange to dark-brown flecks, diameter 9.0 mm, thickness 4.7 mm
 Print on wrapping:
ランソプラゾールOD「トーワ」, 15mg, 口腔内崩壊錠

Effects of this medicine

This medicine inhibits gastric acid secretion by inhibiting enzyme activity of the proton pump in the gastric mucosa.
Usually, used for treatment of gastric/duodenal ulcer, reflux esophagitis, non-erosive gastroesophageal reflux disease, etc., and for suppression of recurrence of gastric/duodenal ulcer associated with low-dose aspirin or nonsteroidal anti-inflammatory drug medication.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you are a patient with hepatic disorder.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • For gastric/duodenal/anastomotic ulcer, Zollinger-Ellison syndrome: In general, for adults, take 2 tablets (30 mg of the active ingredient) at a time, once a day. The treatment period should not exceed 8 weeks for gastric/anastomotic ulcer or 6 weeks for duodenal ulcer.
    For reflux esophagitis: In general, for adults, take 2 tablets (30 mg of the active ingredient) at a time, once a day. The treatment period should not exceed 8 weeks. For maintenance therapy of repeatedly recurrent/relapsing reflux esophagitis, take 1 tablet (15 mg of the active ingredient) at a time, once a day. If the effect is insufficient, the dosage may be increased to 2 tablets (30 mg) at a time, once a day.
    For non-erosive gastroesophageal reflux disease: In general, for adults, take 1 tablet (15 mg of the active ingredient) at a time, once a day. The treatment period should not exceed 4 weeks.
    For suppression of recurrence of gastric/duodenal ulcer associated with low-dose aspirin or nonsteroidal anti-inflammatory drug medication, for adults, take 1 tablet (15 mg of the active ingredient) at a time, once a day.
    In any case, strictly follow the instructions.
  • This medicine is orally-disintegrating tablet. Use either one of the following two methods to take it.
    (1) Take this medicine with water or lukewarm water like an ordinary tablet.
    (2) Place the tablet on your tongue, crush lightly with your tongue and swallow with saliva. However, do not take this medicine without water while in lying position.
  • If you miss a dose, take the missed dose as soon as possible. However, wait approximately 8 hours before the next dose. You should never take two doses at one time.
  • If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
  • Do not stop taking this medicine unless your doctor instructs you to do so.

Precautions while taking this medicine

Possible adverse reactions to this medicine

The most commonly reported side effects include rash, itching, erythema multiforme,constipation, diarrhea, dry mouth, enlarged feeling of abdomen, headache, sleepiness, fever, gynecomastia, etc. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • generalized rash, facial swelling, breathlessness [anaphylaxis, shock]
  • dullness, fever, shortness of breath, nose bleeding/subcutaneous hemorrhage, red-brown urine [pancytopenic, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia]
  • yellowing of the skin or whites of the eyes, dullness, loss of appetite [jaundice, serious hepatic function disorder]
  • fever, general malaise, rash and redness on the skin/eyes and in mouth [toxic epidermal necrolysis, mucocutaneous-ocular syndrome]
  • fever, dry cough, breathlessness [interstitial pneumonia]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

  • Keep out of the reach of children. Store away from direct sunlight, heat and moisture.
  • Discard the remainder. Do not store them.

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z